Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Assessment of Intraspinal Injection of ARTCEREB for Cerebrospinal Fluid Hypovolemia (SUIC study)
jRCTs061210050Recruiting
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of artificial cerebrospinal fluid in idiopathic intracranial hypotension (SIH). Primary endpoint: Safety of CSF refill test with ARTCEREB. Started Apr 2022; status: recruiting.
02
Drugs
artificial cerebrospinal fluid
03
Conditions
idiopathic intracranial hypotension (SIH)
Beyond the preview
Go deeper on jRCTs061210050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061210050.